Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative

Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

(2018) Daniel C. Malone et al.   VALUE IN HEALTH

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

(2017) Marc L. Berger et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies

(2017) Amr Makady et al.   VALUE IN HEALTH

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

(2017) Shirley V. Wang et al.   VALUE IN HEALTH

Guidelines for good pharmacoepidemiology practice (GPP)

(2015)   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

(2014) Marc L. Berger et al.   VALUE IN HEALTH

Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols

(2014) George Peat et al.   PLOS MEDICINE

GRADE guidelines—an introduction to the 10th–13th articles in the series

(2012) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Comparative Effectiveness Research: Challenges for Medical Journals

(2010) Harold C. Sox et al.   CROATIAN MEDICAL JOURNAL

Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II

(2009) Emily Cox et al.   VALUE IN HEALTH

Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III

(2009) Michael L. Johnson et al.   VALUE IN HEALTH

Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I

(2009) Marc L. Berger et al.   VALUE IN HEALTH